drugset
drugset / Trial / NCT01469416

Drug Interaction Study of Clopidogrel and Rosuvastatin

NCT01469416 ↗

Phase 1 Completed 10 enrolled University of California, San Francisco
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to determine if clopidogrel inhibits hepatic uptake transport of rosuvastatin clinically.

Timeline

Start
2012-03
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg Oral
Subject Rosuvastatin Small molecule 20 mg Oral

Indications

No indication recorded.